i-sense: EPSRC IRC in Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance (i-sense COVID-19: Harnessing digital and diagnostic technologies for COVID-19)
- Funded by UK Research and Innovation (UKRI)
- Total publications:60 publications
Grant number: EP/R00529X/1
Grant search
Key facts
Disease
COVID-19Start & end year
20182022Known Financial Commitments (USD)
$5,276,860.74Funder
UK Research and Innovation (UKRI)Principal Investigator
R McKendryResearch Location
United KingdomLead Research Institution
University College LondonResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
Innovation
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Additional funding for the I-sense IRC to address the COVID-19 Pandemic. Vision: To harness the multidisciplinary expertise within the i-sense EPSRC IRC track and test Flagship programmes to address the key challenges associated with the COVID-19 pandemic; namely early identification of infection in the community through online data sources and point-of-care diagnostic tests (PoCT) linked to national health systems. We request £500K of emergency funding initially to seed a 12 month 'Plus Award' focused on urgent national needs
Publicationslinked via Europe PMC
Last Updated:a day ago
View all publications at Europe PMC